Early Outcomes After Total Arch Replacement With Frozen Elephant Trunk in Elderly Patients With Acute Type A Aortic Dissection Authors: Jiajun Liang, Yuan Xue, Yeting Lou, Hao Han, Xiaohan Zhong, Zhou Liu, Tianxu Han, Meili Wang, Wenjian Jiang, Hongjia Zhang, Haiyang Li, Yuanfei Zhao Published: 2026 ABSTRACT ABSTRACTObjectiveThe clinical efficacy and early outcomes of total arch replacement with frozen elephant trunk (TAR+FET) in elderly patients presenting with acute type A aortic dissection (ATAAD) remain incompletely characterized. This study aimed to comprehensively evaluate early clinical outcomes and perioperative risk profiles in elderly patients undergoing TAR+FET for ATAAD, thereby addressing gaps in the literature and providing evidence to guide surgical decision‐making in this high‐risk population.MethodsA multicenter retrospective analysis was conducted involving 1634 patients who underwent TAR+FET for ATAAD between 2015 and 2023 across seven cardiovascular centers. Patients were categorized into elderly (≥ 60 years, n = 258) and non‐elderly (< 60 years, n = 1376) groups. Baseline characteristics, operative details, and early outcomes were compared between groups before propensity score matching (PSM). A 1:2 PSM established a balanced cohort of 699 patients (elderly, n = 245; non‐elderly, n = 454), in which postoperative complications and survival were compared. To evaluate the independent prognostic impact of age, multivariable Cox proportional hazards models with incremental covariate adjustments were applied.ResultsBefore PSM, elderly patients had higher prevalences of coronary artery disease, diabetes, and hyperlipidemia, with significantly longer intensive care unit (ICU) stay, prolonged ventilation time, and lower 30‐day survival compared with non‐elderly patients. After PSM, baseline covariates were well balanced; however, elderly patients continued to demonstrate worse perioperative outcomes, including longer ICU stay (68 [35–162] vs. 47 [28–113] h, p = 0.001), prolonged ventilation time (49 [21–111] vs. 38 [18–86] h, p < 0.001), and higher incidences of reintubation, tracheostomy, respiratory failure, acute kidney injury (AKI), and dialysis (all p < 0.010). Kaplan–Meier analysis revealed significantly lower 30‐day survival in the elderly group (86.5% vs. 93.6%, p = 0.002). Multivariable Cox regression identified age ≥ 60 years as an independent predictor of mortality (hazard ratio = 2.286, 95% confidence interval: 1.361–3.840, p = 0.002). Within the elderly subgroup, non‐survivors were older, had longer operative and cardiopulmonary bypass times, and experienced substantially higher rates of severe postoperative complications—particularly neurological injury, dialysis‐requiring AKI, arrhythmia, and respiratory failure—than survivors.ConclusionEven after adjustment for baseline characteristics, elderly patients undergoing TAR+FET have higher risks of perioperative complications and early mortality than non‐elderly patients. This unfavorable prognosis likely reflects reduced physiological reserve rather than surgical factors alone. Future strategies should emphasize individualized procedure selection and organ‐protective perioperative management to improve outcomes in this population. Introduction Acute type A aortic dissection (ATAAD) is a life‐threatening surgical emergency associated with exceedingly high mortality in the absence of prompt intervention [1]. Current guidelines therefore recommend urgent operative repair and, in many high‐volume centers, total arch replacement with frozen elephant trunk (TAR+FET) is employed to address arch pathology and promote distal aortic remodeling [2]. Large single‐center series with Sun's procedure have demonstrated feasibility, with a reported 7.8% early mortality and 2.5% permanent neurological deficit [3]. Pooled multicenter data further indicate short‐term risks among patients with ATAAD undergoing TAR+FET, including 9.2% early mortality, 4.8% stroke, and 3.5% spinal cord injury [4]. Advanced age is associated with a progressive risk gradient in ATAAD. This gradient is illustrated in TAR+FET cohorts, in which septuagenarians have an in‐hospital mortality rate of approximately 24%, compared with 13% in patients younger than 70 years [5]. Among octogenarians, short‐term mortality is nearly doubled, and 5‐year survival is lower than in younger patients [6]. In contrast, contemporary studies involving mixed‐age cohorts report more favorable outcomes, with early mortality ranging from 6% to 8% and permanent neurological deficits occurring in 2%–3% of patients [3, 7]. Whether these short‐term benefits extend to elderly patients, however, remains uncertain for several reasons. First, many frail elderly patients are triaged to less extensive surgical approaches or nonoperative management; therefore, those undergoing TAR+FET represent a selected subgroup with greater physiologic reserve. Second, key geriatric risk determinants are inconsistently measured or standardized across studies, and residual confounding may persist despite statistical adjustment. Third, perioperative management strategies, device selection, and institutional experience vary across centers and over time, introducing heterogeneity that may influence outcomes. Fourth, outcome definitions and the time frame for “early” events (e.g., in‐hospital vs. 30‐day) are not uniform. Collectively, these factors limit the generalizability of pooled short‐term estimates to the broader elderly population, and the benefit–risk balance likely depends on center‐specific protocols and patients' physiologic reserve [4, 5, 6]. Accordingly, this study aimed to systematically characterize early clinical outcomes and perioperative risk profiles of elderly patients with ATAAD undergoing TAR+FET in a large multicenter cohort, thereby addressing existing evidence gaps and informing surgical decision‐making in this high‐risk population. Methods Study Design and Population This multicenter, retrospective observational cohort study was conducted across seven cardiovascular centers. At all participating centers, TAR+FET, following Sun's procedure, was used as the standard operative strategy, with broadly consistent intraoperative cerebral protection principles. Between January 2015 and December 2023, 1911 consecutive patients diagnosed with type A aortic dissection and treated with TAR+FET were screened. Patients with (1) subacute or chronic type A dissection, or (2) incomplete essential clinical or imaging data were excluded. Therefore, all primary analyses were performed using a complete‐case dataset. After applying these criteria, 1634 patients with ATAAD were eligible for analysis. Patients were stratified by age into two groups: elderly (≥ 60 years, n = 258) and non‐elderly (< 60 years, n = 1376). The age threshold of 60 years was prespecified because it is widely used to define older adults in population aging frameworks, represents the statutory definition of older persons in China, and has been commonly applied in clinical studies of thoracic aortic disease [8, 9]. To minimize baseline imbalances, propensity score matching (PSM) was performed at a 1:2 ratio, yielding a final matched cohort of 699 patients (245 elderly and 454 non‐elderly). The study was approved by the institutional ethics committee (KS2024114), and the requirement for individual informed consent was waived due to the retrospective study design (Figure 1). Study design. PSM, propensity score matching; TAR+FET, total aortic arch replacement + frozen elephant trunk stent graft implantation. Data Collection Clinical data were retrieved from electronic medical records and operative databases. Baseline variables included demographic characteristics (age, sex, and body mass index [BMI]), lifestyle factors (smoking and alcohol use), comorbidities (hypertension, diabetes, hyperlipidemia, coronary heart disease, cerebrovascular disease, and connective tissue disorders), and previous cardiovascular interventions (percutaneous coronary intervention [PCI], thoracic endovascular aortic repair [TEVAR], or cardiac surgery). Preoperative echocardiographic parameters included left ventricular end‐systolic diameter (LVESD), left ventricular end‐diastolic diameter (LVEDD), and left ventricular ejection fraction (LVEF). Operative variables included cardiopulmonary bypass (CPB), aortic cross‐clamp (ACC) time, hypothermic circulatory arrest duration and temperature, cerebral perfusion approach, cannulation strategy, and proximal aortic procedures. Postoperative outcomes, in‐hospital complications, intensive care unit (ICU) stay, ventilation time, and survival status were systematically collected. Definitions and Endpoints ATAAD was defined as a dissection involving the ascending aorta with symptom onset within 14 days, confirmed by contrast‐enhanced computed tomography angiography (CTA). Subacute (15–90 days) and chronic (> 90 days) dissections were excluded. The primary endpoint was all‐cause 30‐day mortality. Thirty‐day mortality status was available for all patients in the analytic cohort. Secondary endpoints included major postoperative complications: reintubation, tracheostomy, stroke (ischemic or hemorrhagic), dialysis‐requiring acute kidney injury (AKI), respiratory failure, low cardiac output syndrome, arrhythmia, limb ischemia, cardiac tamponade, and reoperation for postoperative bleeding. All postoperative complications were assessed during the index hospitalization, defined as the period from the date of operation to hospital discharge or in‐hospital death. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria as an increase in serum creatinine by ≥ 0.3 mg/dL within 48 h, an increase to ≥ 1.5 times baseline within 7 days, or urine output < 0.5 mL/kg/h for ≥ 6 h. Dialysis‐dependent AKI was defined as initiation of renal replacement therapy post‐surgery during index hospitalization. Neurological complications were classified as stroke, defined as a new permanent neurological deficit confirmed by imaging (ischemic or hemorrhagic), or temporary neurological dysfunction, defined as reversible neurological symptoms without radiographic evidence of cerebral injury. Respiratory failure was defined as a composite endpoint including prolonged mechanical ventilation (> 48 h), reintubation, or tracheostomy during the index hospitalization. Ventilation time was reported as a continuous measure of ventilatory support and was not considered an independent postoperative complication. Low cardiac output syndrome was defined as postoperative hypoperfusion requiring sustained inotropic or vasoactive support to maintain adequate systemic perfusion, or the use of mechanical circulatory support, including an intra‐aortic balloon pump or extracorporeal membrane oxygenation (ECMO), as documented in ICU records. Other complications were defined according to established consensus: arrhythmia as atrial or ventricular rhythm disturbances requiring intervention; cardiac tamponade as hemodynamic compromise with echocardiographic confirmation requiring surgical or percutaneous drainage; limb ischemia as clinically evident peripheral malperfusion requiring treatment; and reoperation as surgical re‐exploration for bleeding, tamponade, or graft‐related complications. All outcomes were prespecified and recorded using standardized definitions across centers. Events were ascertained from operative and ICU records, laboratory data, and imaging reports, with coordinating‐center data checks and source‐document verification for discrepant entries. Survival time was calculated from the date of operation to death from any cause or the last available follow‐up. Surgical Procedure All operations were performed using the standardized TAR+FET technique, which has been previously described [10]. In brief, surgery was performed via median sternotomy under general anesthesia. CPB was established through right axillary, femoral, or dual arterial cannulation, with right atrial venous drainage. Selective antegrade cerebral perfusion (SACP) was applied during hypothermic circulatory arrest, with nasopharyngeal temperature individualized within a moderate‐to‐low hypothermia range according to patient condition and perfusion strategy. A stented elephant trunk graft was deployed into the descending thoracic aorta, followed by reconstruction of the total arch using a four‐branched prosthetic graft. The proximal aortic procedure (isolated ascending aortic replacement or Bentall procedure) was selected based on the extent of aortic involvement and the presence of valvular pathology. Concomitant procedures, such as coronary artery bypass grafting (CABG), were performed when indicated. Cerebral protection was provided with SACP. Unilateral perfusion was generally adopted in patients with favorable arch vessel anatomy and an intact circle of Willis, whereas bilateral perfusion was applied in those with complex cerebrovascular anatomy, inadequate collateral circulation, or when prolonged circulatory arrest was anticipated. Perfusion flow rate was maintained at 8–10 mL/kg/min with a target right radial arterial pressure of 50–70 mmHg to ensure adequate cerebral perfusion. Core temperature was monitored at nasopharyngeal and rectal sites, and the target nasopharyngeal temperature during circulatory arrest was approximately 24°C–26°C. A commercially available frozen elephant trunk stent graft was used, with length and diameter selected based on preoperative CTA measurements and intraoperative assessment. Operative strategies were guided by anatomic and physiologic considerations rather than age; Table 1 provides comparisons between age groups. Postoperative intensive care management followed routine protocols at each center. Mechanical ventilation and weaning were guided by clinical stability, with extubation pursued once hemodynamic stability, normothermia, adequate gas exchange, and hemostasis were achieved. Reintubation or tracheostomy was performed when clinically indicated. Transfusion and bleeding management were guided by clinical assessment and routine laboratory testing, with blood products administered as needed. These perioperative practices were individualized according to patient condition and were not protocolized by age group. TABLE 1Surgical details.VariablesBefore PSM p After PSM p OverallAge < 60Age ≥ 60OverallAge < 60Age ≥ 60 n = 1634 n = 1376 n = 258 n = 699 n = 454 n = 245Operating time (h), Median (Q1, Q3)7.00 (6.00, 8.00)7.00 (6.00, 8.00)8.00 (6.50, 8.00)0.0087.00 (6.50, 8.00)7.00 (6.50, 8.00)8.00 (6.50, 8.00)0.491CPB time, Median (Q1, Q3)197 (172, 224)197 (172, 224)196 (170, 224)0.993196 (170, 226)196 (170, 227)196 (170, 224)0.929ACC time, Median (Q1, Q3)108 (92, 129)108 (92, 129)109 (90, 130)0.822109 (92, 131)108 (92, 130)109 (91, 132)0.729Cerebral blood flow, mL/(kg.min), Median (Q1, Q3)5.00 (5.00, 6.00)5.00 (5.00, 6.00)5.00 (5.00, 7.00)0.0145.00 (5.00, 6.00)5.00 (5.00, 6.00)5.00 (5.00, 7.00)0.091HCA time, Median (Q1, Q3)22 (17, 30)22 (17, 30)22 (17, 33)0.72122 (17, 30)22 (17, 30)23 (17, 33)0.374Nasopharyngeal Temperature, Median (Q1, Q3)24.50 (23.80, 25.10)24.50 (23.80, 25.10)24.60 (23.90, 25.30)0.14024.60 (23.90, 25.20)24.50 (23.80, 25.20)24.60 (23.90, 25.30)0.457Cannulation strategy, n (%)0.1720.472Axillary or femoral cannulation1145 (70.1%)955 (69.4%)190 (73.6%)499 (71.4%)320 (70.5%)179 (73.1%)Dual arterial cannulation489 (29.9%)421 (30.6%)68 (26.4%)200 (28.6%)134 (29.5%)66 (26.9%)Cerebral perfusion approach, n (%)0.0190.753Unilateral cerebral perfusion1439 (88.1%)1223 (88.9%)216 (83.7%)589 (84.3%)384 (84.6%)205 (83.7%)Bilateral cerebral perfusion195 (11.9%)153 (11.1%)42 (16.3%)110 (15.7%)70 (15.4%)40 (16.3%)Proximal aortic procedure, n (%)0.0150.970None4 (0.2%)3 (0.2%)1 (0.4%)3 (0.4%)2 (0.4%)1 (0.4%)Isolated ascending aortic replacement1007 (61.6%)829 (60.2%)178 (69.0%)475 (68.0%)309 (68.1%)166 (67.8%)Bentall procedure623 (38.1%)544 (39.5%)79 (30.6%)221 (31.6%)143 (31.5%)78 (31.8%)Concomitant CABG, n (%)112 (6.9%)82 (6.0%)30 (11.6%)< 0.00179 (11.3%)51 (11.2%)28 (11.4%)0.938 Note: p values were calculated using the Wilcoxon rank‐sum test for continuous variables and the Pearson chi‐square test for categorical variables, with Fisher exact test applied when expected cell counts were small.Abbreviations: ACC, aortic cross‐clamping; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; HCA, hypothermic circulatory arrest. Surgical details. Note: p values were calculated using the Wilcoxon rank‐sum test for continuous variables and the Pearson chi‐square test for categorical variables, with Fisher exact test applied when expected cell counts were small. Abbreviations: ACC, aortic cross‐clamping; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; HCA, hypothermic circulatory arrest. Statistical Analysis Continuous variables are presented as medians with interquartile ranges (IQR) and were compared using the Mann–Whitney U test due to non‐normal distributions. Categorical variables are expressed as counts and percentages and compared using the chi‐square test or Fisher's exact test, as appropriate. To minimize baseline imbalances, PSM was performed at a 1:2 ratio (elderly: non‐elderly) using nearest‐neighbor matching without replacement and a caliper width of 0.2 of the logit of the propensity score. Matching was conducted using the R package MatchIt. Patients with missing data for variables used for propensity score estimation were excluded before PSM. Variables included in the logistic regression model for propensity score calculation were demographic characteristics, comorbidities, preoperative echocardiographic parameters, and operative characteristics. Propensity score overlap between groups was examined to ensure adequate common support before matching. Covariate balance after matching was assessed using standardized mean differences, with an absolute value < 0.1 considered acceptable. Survival was analyzed using the Kaplan–Meier method, and between‐group differences were evaluated with the log‐rank test. The prognostic role of age (≥ 60 vs. < 60 years) was further assessed using Cox proportional hazards regression models with incremental covariate adjustment to evaluate its independent association with postoperative mortality. A two‐tailed p‐value < 0.05 was considered statistically significant. All analyses were performed using R software (version 4.2.1; R Foundation for Statistical Computing, Vienna, Austria). As sensitivity analyses, the primary models were repeated using alternative age thresholds of 65, 70, and 80 years, and the age distribution within the elderly group was summarized to assess within‐group heterogeneity. Results Baseline Characteristics Of 1911 patients screened, 1634 patients with ATAAD undergoing TAR+FET were included, comprising 258 elderly (≥ 60 years, 15.8%) and 1376 non‐elderly (< 60 years, 84.2%) patients. The overall median age was 49 years (IQR, 41–56). Median age was 63 years (61–66) in the elderly and 47 years (39–52) in the non‐elderly (p < 0.001). Before PSM, elderly patients were less frequently male (59.3% vs. 82.8%, p < 0.001) and had a lower prevalence of smoking (21.7% vs. 38.2%, p < 0.001). They also had higher prevalences of diabetes (8.5% vs. 3.3%), hyperlipidemia (8.1% vs. 3.6%), coronary artery disease (7.0% vs. 2.6%), cerebrovascular disease (6.2% vs. 2.3%), and prior PCI (5.0% vs. 1.5%; all p < 0.001). Echocardiography showed a higher frequency of moderate‐to‐severe aortic regurgitation (≥ 2+: 47.3% vs. 39.6%, p = 0.012) and pericardial effusion (any grade: 42.6% vs. 34.7%, p = 0.015) in elderly patients. After 1:2 PSM, 699 patients (245 elderly, 454 non‐elderly) were included. Baseline characteristics were well balanced between groups, except for the predefined age criterion (all p > 0.050; Table 2, Figure 2, Table S1). In the matched cohort, the overall median age was 54 years (IQR, 46–62), with median ages of 63 (IQR, 61–66) and 49 (IQR, 41–53) years in the elderly and non‐elderly groups, respectively. TABLE 2Baseline characteristics.CharacteristicBefore PSM p After PSM p OverallAge < 60Age ≥ 60OverallAge < 60Age ≥ 60 n = 1634 n = 1376 n = 258 n = 699 n = 454 n = 245Age, Median (Q1, Q3)49 (41, 56)47 (39, 52)63 (61, 66)< 0.00154 (46, 62)49 (41, 53)63 (61, 66)< 0.001Gender (Male), n (%)1292 (79.1%)1139 (82.8%)153 (59.3%)< 0.001450 (64.4%)299 (65.9%)151 (61.6%)0.266BMI, Median (Q1, Q3)26.2 (24.0, 29.3)26.4 (24.2, 29.4)25.6 (23.4, 27.7)< 0.00125.7 (23.4, 27.8)25.7 (23.2, 28.1)25.6 (23.4, 27.7)0.654Smoke, n (%)750 (45.9%)644 (46.8%)106 (41.1%)0.091295 (42.2%)194 (42.7%)101 (41.2%)0.700Drunk, n (%)474 (29.0%)408 (29.7%)66 (25.6%)0.186178 (25.5%)113 (24.9%)65 (26.5%)0.635Hypertension, n (%)1252 (76.6%)1052 (76.5%)200 (77.5%)0.71536 (76.7%)347 (76.4%)189 (77.1%)0.832Diabetes, n (%)67 (4.1%)45 (3.3%)22 (8.5%)< 0.00152 (7.4%)33 (7.3%)19 (7.8%)0.815Hyperlipidemia, n (%)70 (4.3%)49 (3.6%)21 (8.1%)< 0.00143 (6.2%)26 (5.7%)17 (6.9%)0.525Marfan syndrome, n (%)11 (0.7%)11 (0.8%)0 (0.0%)0.2315 (0.7%)5 (1.1%)0 (0.0%)0.168Renal malperfusion, n (%)53 (3.2%)45 (3.3%)8 (3.1%)0.88822 (3.1%)14 (3.1%)8 (3.3%)0.896History of CHD, n (%)54 (3.3%)36 (2.6%)18 (7.0%)< 0.00131 (4.4%)19 (4.2%)12 (4.9%)0.662History of MI, n (%)11 (0.7%)7 (0.5%)4 (1.6%)0.0814 (0.6%)3 (0.7%)1 (0.4%)> 0.999History of CVD, n (%)54 (3.3%)39 (2.8%)15 (5.8%)0.01430 (4.3%)16 (3.5%)14 (5.7%)0.173History of heart surgery, n (%)41 (2.5%)34 (2.5%)7 (2.7%)0.81920 (2.9%)13 (2.9%)7 (2.9%)0.996History of TEVAR, n (%)23 (1.4%)18 (1.3%)5 (1.9%)0.39210 (1.4%)6 (1.3%)4 (1.6%)0.747History of aortic surgery, n (%)48 (2.9%)39 (2.8%)9 (3.5%)0.56826 (3.7%)18 (4.0%)8 (3.3%)0.641History of PCI, n (%)15 (0.9%)8 (0.6%)7 (2.7%)0.0056 (0.9%)2 (0.4%)4 (1.6%)0.191AR, n (%)< 0.0010.863None720 (44.1%)639 (46.4%)81 (31.4%)232 (33.2%)154 (33.9%)78 (31.8%)Mild569 (34.8%)445 (32.3%)124 (48.1%)313 (44.8%)199 (43.8%)114 (46.5%)Moderate221 (13.5%)182 (13.2%)39 (15.1%)117 (16.7%)78 (17.2%)39 (15.9%)Severe124 (7.6%)110 (8.0%)14 (5.4%)37 (5.3%)23 (5.1%)14 (5.7%)MR, n (%)0.1010.279None1155 (70.7%)974 (70.8%)181 (70.2%)478 (68.4%)307 (67.6%)171 (69.8%)Mild455 (27.8%)386 (28.1%)69 (26.7%)206 (29.5%)140 (30.8%)66 (26.9%)Moderate19 (1.2%)13 (0.9%)6 (2.3%)12 (1.7%)6 (1.3%)6 (2.4%)Severe5 (0.3%)3 (0.2%)2 (0.8%)3 (0.4%)1 (0.2%)2 (0.8%)TR, n (%)0.1180.436None1228 (75.2%)1044 (75.9%)184 (71.3%)508 (72.7%)336 (74.0%)172 (70.2%)Mild372 (22.8%)306 (22.2%)66 (25.6%)172 (24.6%)107 (23.6%)65 (26.5%)Moderate28 (1.7%)20 (1.5%)8 (3.1%)17 (2.4%)9 (2.0%)8 (3.3%)Severe6 (0.4%)6 (0.4%)0 (0.0%)2 (0.3%)2 (0.4%)0 (0.0%)Pericardial effusion, n (%)< 0.0010.701None1342 (82.1%)1146 (83.3%)196 (76.0%)554 (79.3%)364 (80.2%)190 (77.6%)Mild260 (15.9%)211 (15.3%)49 (19.0%)124 (17.7%)78 (17.2%)46 (18.8%)Moderate28 (1.7%)16 (1.2%)12 (4.7%)19 (2.7%)11 (2.4%)8 (3.3%)Severe4 (0.2%)3 (0.2%)1 (0.4%)2 (0.3%)1 (0.2%)1 (0.4%)LVESD, Median (Q1, Q3)31.0 (29.0, 34.0)31.0 (29.0, 34.0)31.0 (28.0, 32.0)< 0.00131.0 (28.0, 33.0)31.0 (27.0, 33.0)31.0 (28.0, 32.0)0.666LVEDD, Median (Q1, Q3)48 (44, 52)48 (45, 53)47 (43, 50)< 0.00147.0 (43.0, 50.0)47.0 (43.0, 50.0)47.0 (43.0, 50.0)0.835LVEF, Median (Q1, Q3)62.0 (59.0, 65.0)62.0 (59.0, 65.0)62.0 (60.0, 65.0)0.53062.0 (60.0, 65.0)62.0 (60.0, 65.0)62.0 (60.0, 65.0)0.362 Note: p values were calculated using the Wilcoxon rank‐sum test for continuous variables and the Pearson chi‐square test for categorical variables, with Fisher exact test applied when expected cell counts were small.Abbreviations: AR, aortic regurgitation; BMI, Body mass index; CHD, coronary heart disease; CVD, cerebrovascular disease; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end‐systolic diameter; MI, myocardial infarction; MR, mitral regurgitation; PCI, percutaneous coronary intervention; TR, tricuspid regurgitation. Baseline characteristics. Note: p values were calculated using the Wilcoxon rank‐sum test for continuous variables and the Pearson chi‐square test for categorical variables, with Fisher exact test applied when expected cell counts were small. Abbreviations: AR, aortic regurgitation; BMI, Body mass index; CHD, coronary heart disease; CVD, cerebrovascular disease; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end‐systolic diameter; MI, myocardial infarction; MR, mitral regurgitation; PCI, percutaneous coronary intervention; TR, tricuspid regurgitation. Covariate balance. AR, aortic regurgitation; BMI, body mass index; CABG, coronary artery bypass grafting; CHD, coronary heart disease; IAAR, isolated ascending aortic replacement; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end‐systolic diameter. Operative Details Table 1 summarizes operative characteristics. In the unmatched cohort, elderly patients more frequently underwent concomitant CABG (11.6% vs. 6.0%, p < 0.001) and bilateral cerebral perfusion (16.3% vs. 11.1%, p = 0.019). Median operative time was slightly longer in elderly patients (8.0 [IQR, 6.5–8.0] vs. 7.0 [6.0–8.0] hours, p = 0.008). CPB and ACC times were similar between groups (196 [170–224] vs. 197 [172–224] minutes, p = 0.993; and 109 [90–130] vs. 108 [92–129] minutes, p = 0.822, respectively). After PSM, all operative variables were comparable, including CPB time (196 [170–224] vs. 196 [170–227] minutes, p = 0.929), ACC time (109 [91–132] vs. 108 [92–130] minutes, p = 0.729), and proximal aortic procedure (Bentall procedure: 31.8% vs. 31.5%, p = 0.970). Cannulation approach, cerebral protection strategy, temperature targets, and major operative times were also well balanced between groups in the matched cohort (Table 1). Early Mortality In the overall cohort, 30‐day all‐cause mortality was 7.1% (116/1634). Mortality was significantly higher in elderly than in non‐elderly patients (14.3% [37/258] vs. 5.7% [79/1376], p < 0.001). After PSM, the difference remained significant (13.5% [33/245] vs. 6.4% [29/454], p = 0.002; Table 3). Kaplan–Meier survival analysis demonstrated significantly lower early survival in elderly patients compared with non‐elderly patients (log‐rank p = 0.002; Figure 3). Most deaths occurred within the first seven postoperative days, with the steepest decline in survival observed during the early perioperative period. TABLE 3Early outcomes.CharacteristicsBefore PSM p After PSM p OverallAge < 60Age ≥ 60OverallAge < 60Age ≥ 60 n = 1634 n = 1376 n = 258 n = 699 n = 454 n = 245Survival< 0.0010.0025‐day survival, % (95% CI)96.7 (95.8, 97.7)91.1 (87.7, 94.6)95.8 (94.0, 97.7)91.8 (88.5, 95.3)10‐day survival, % (95% CI)96.0 (95.0, 97.0)89.5 (85.9, 93.4)95.2 (93.2, 97.2)90.6 (87.0, 94.3)15‐day survival, % (95% CI)95.0 (93.8, 96.2)88.0 (84.1, 92.0)94.5 (92.4, 96.6)89.0 (85.1, 93.0)30‐day survival, % (95% CI)94.3 (93.0, 96.0)85.7 (81.5, 90.0)93.6 (91.4, 95.9)86.5 (82.4, 90.9)30‐day mortality, n (%)116 (7.1%)79 (5.7%)37 (14.3%)< 0.00162 (8.9%)29 (6.4%)33 (13.5%)0.002Reoperation, n (%)88 (5.4%)65 (4.7%)23 (8.9%)0.00642 (6.0%)20 (4.4%)22 (9.0%)0.015 Early outcomes. Kaplan–Meier curve before PSM (A) and after PSM (B). x axis: follow‐up time since surgery (days); y axis: rate of survival probability. Postoperative Complications Table 4 summarizes postoperative complications. Before matching, elderly patients had significantly higher rates of respiratory, renal, cardiovascular, and neurological complications than non‐elderly patients. TABLE 4Postoperative outcomes.VariablesBefore PSM p After PSM p OverallAge < 60Age ≥ 60OverallAge < 60Age ≥ 60 n = 1634 n = 1376 n = 258 n = 699 n = 454 n = 245ICU‐LOS, Median (Q1, Q3)51 (26, 111)44 (22, 107)71 (36, 163)< 0.00159 (33, 131)47 (28, 113)68 (35, 162)0.001Ventilation time, Median (Q1, Q3)38 (17, 86)37 (17, 81)50 (21, 114)< 0.00140 (19, 97)38 (18, 86)49 (21, 111)< 0.001Respiratory failure, n (%)667 (40.8%)535 (38.9%)132 (51.2%)< 0.001299 (42.8%)176 (38.8%)123 (50.2%)0.004Prolonged ventilation > 48 h661 (40.4%)529 (38.4%)132 (51.2%)< 0.001296 (42.3%)173 (38.1%)123 (50.2%)0.002Reintubation62 (3.8%)45 (3.3%)17 (6.6%)0.01024 (3.4%)9 (2.0%)15 (6.1%)0.004Tracheostomy56 (3.4%)41 (3.0%)15 (5.8%)0.02226 (3.7%)11 (2.4%)15 (6.1%)0.014Positive Neuroimaging Findings, n (%)0.0660.087Negative1411 (86.4%)1200 (87.2%)211 (81.8%)601 (86.0%)400 (88.1%)201 (82.0%)Positive89 (5.4%)70 (5.1%)19 (7.4%)37 (5.3%)20 (4.4%)17 (6.9%)Not tested134 (8.2%)106 (7.7%)28 (10.9%)61 (8.7%)34 (7.5%)27 (11.0%)Stroke, n (%)113 (6.9%)90 (6.5%)23 (8.9%)0.16852 (7.4%)30 (6.6%)22 (9.0%)0.254Intracerebral hemorrhage, n (%)21 (1.3%)20 (1.5%)1 (0.4%)0.23210 (1.4%)9 (2.0%)1 (0.4%)0.178Cerebral infarction, n (%)102 (6.2%)80 (5.8%)22 (8.5%)0.09846 (6.6%)25 (5.5%)21 (8.6%)0.119Paraplegia, n (%)51 (3.1%)44 (3.2%)7 (2.7%)0.68119 (2.7%)12 (2.6%)7 (2.9%)0.868PND, n (%)153 (9.4%)125 (9.1%)28 (10.9%)0.37167 (9.6%)40 (8.8%)27 (11.0%)0.344Limb paralysis, n (%)4 (0.2%)4 (0.3%)0 (0.0%)> 0.9992 (0.3%)2 (0.4%)0 (0.0%)0.544Limb ischemia, n (%)70 (4.3%)41 (3.0%)29 (11.2%)< 0.00139 (5.6%)11 (2.4%)28 (11.4%)< 0.001Acute kidney injury, n (%)157 (9.6%)110 (8.0%)47 (18.2%)< 0.00180 (11.4%)37 (8.1%)43 (17.6%)< 0.001Postoperative dialysis, n (%)191 (11.7%)140 (10.2%)51 (19.8%)< 0.00199 (14.2%)51 (11.2%)48 (19.6%)0.002Cardiac tamponade, n (%)14 (0.9%)9 (0.7%)5 (1.9%)0.0567 (1.0%)2 (0.4%)5 (2.0%)0.055Arrhythmia, n (%)166 (10.2%)109 (7.9%)57 (22.1%)< 0.001102 (14.6%)47 (10.4%)55 (22.4%)< 0.001ECMO, n (%)31 (1.9%)23 (1.7%)8 (3.1%)0.13417 (2.4%)9 (2.0%)8 (3.3%)0.293IABP, n (%)55 (3.4%)43 (3.1%)12 (4.7%)0.21217 (2.4%)5 (1.1%)12 (4.9%)0.002Lung infection, n (%)146 (8.9%)113 (8.2%)33 (12.8%)0.01874 (10.6%)41 (9.0%)33 (13.5%)0.069Pleural effusion, n (%)416 (25.5%)335 (24.3%)81 (31.4%)0.017188 (26.9%)115 (25.3%)73 (29.8%)0.204Pneumothorax, n (%)45 (2.8%)35 (2.5%)10 (3.9%)0.23016 (2.3%)7 (1.5%)9 (3.7%)0.072Delayed sternal closure, n (%)18 (1.1%)14 (1.0%)4 (1.6%)0.51010 (1.4%)6 (1.3%)4 (1.6%)0.747Postoperative bleeding, n (%)30 (1.8%)22 (1.6%)8 (3.1%)0.12416 (2.3%)8 (1.8%)8 (3.3%)0.205Sternal dehiscence, n (%)10 (0.6%)9 (0.7%)1 (0.4%)> 0.9994 (0.6%)3 (0.7%)1 (0.4%)> 0.999Debridement, n (%)22 (1.3%)18 (1.3%)4 (1.6%)0.76711 (1.6%)7 (1.5%)4 (1.6%)> 0.999Incision infection, n (%)26 (1.6%)21 (1.5%)5 (1.9%)0.58914 (2.0%)9 (2.0%)5 (2.0%)> 0.999Sepsis, n (%)18 (1.1%)12 (0.9%)6 (2.3%)0.0516 (0.9%)0 (0.0%)6 (2.4%)0.002Hospital‐LOS, Median (Q1, Q3)13 (9, 17)13 (9, 17)14 (10, 19)0.12113 (10, 17)13 (10, 17)14 (10, 19)0.165 Note: Postoperative complications were defined as events occurring during the index hospitalization. Respiratory failure was analyzed as a composite endpoint consisting of prolonged ventilation beyond 48 h, reintubation, or tracheostomy; component events are shown for descriptive purposes. p values were calculated using the Wilcoxon rank‐sum test for continuous variables and the Pearson chi‐square test for categorical variables, with Fisher exact test applied when expected cell counts were small.Abbreviations: ECMO, extracorporeal membrane oxygenation; Hospital‐LOS, hospital length of stay; IABP, intra‐aortic balloon pump; ICU‐LOS, intensive care unit length of stay; PND, permanent neurological deficit. Postoperative outcomes. Note: Postoperative complications were defined as events occurring during the index hospitalization. Respiratory failure was analyzed as a composite endpoint consisting of prolonged ventilation beyond 48 h, reintubation, or tracheostomy; component events are shown for descriptive purposes. p values were calculated using the Wilcoxon rank‐sum test for continuous variables and the Pearson chi‐square test for categorical variables, with Fisher exact test applied when expected cell counts were small. Abbreviations: ECMO, extracorporeal membrane oxygenation; Hospital‐LOS, hospital length of stay; IABP, intra‐aortic balloon pump; ICU‐LOS, intensive care unit length of stay; PND, permanent neurological deficit. Respiratory complications were more frequent in elderly patients, including reintubation (6.6% vs. 3.3%, p = 0.010), tracheostomy (5.8% vs. 3.0%, p = 0.022), and respiratory failure (10.9% vs. 4.5%, p < 0.001). Ventilation time was also longer in the elderly group (50 [IQR, 21–114] vs. 37 [17–81] hours, p < 0.001). Renal complications were more common among elderly patients, with higher rates of AKI (18.2% vs. 8.0%, p < 0.001) and postoperative dialysis (19.8% vs. 10.2%, p < 0.001). Cardiovascular complications, particularly arrhythmia (22.1% vs. 7.9%, p < 0.001) and limb ischemia (11.2% vs. 3.0%, p < 0.001), were also more frequent in elderly patients. Neurologic complications (e.g., stroke) were numerically higher in the elderly group (5.4% vs. 3.2%), although not statistically significant (p = 0.085). Pulmonary infection (9.7% vs. 6.7%) and pleural effusion (12.4% vs. 8.7%) were also more common in elderly patients, but these differences were not statistically significant (both p > 0.050). After PSM, elderly patients continued to demonstrate higher respiratory complications, including reintubation (6.1% vs. 2.0%, p = 0.004), tracheostomy (6.1% vs. 2.4%, p = 0.014), and respiratory failure (10.6% vs. 3.5%, p < 0.001). Renal complications remained more frequent in elderly patients, with higher rates of AKI (17.6% vs. 8.1%, p < 0.001) and dialysis (19.6% vs. 11.2%, p = 0.002). Arrhythmia was also more common in elderly patients (22.4% vs. 10.4%, p < 0.001). Rates of neurologic complications (5.3% vs. 3.3%, p = 0.198), pulmonary infection (9.8% vs. 6.6%, p = 0.151), and pleural effusion (12.2% vs. 8.6%, p = 0.121) remained numerically higher in elderly patients but did not differ significantly. ICU length of stay was significantly longer in elderly patients (68 [IQR, 35–162] vs. 47 [28–113] hours, p = 0.001). Overall, elderly patients experienced consistently higher rates of major postoperative complications—particularly respiratory, renal, cardiovascular, and neurological events—even after adjustment for baseline differences using PSM. Cox Regression Analysis To evaluate the independent effect of age on early mortality, potential confounders were initially screened using univariable Cox regression (p < 0.050) and subsequently incorporated into multivariable Cox models with sequential adjustment (Tables 5 and 6). In Model 1 (adjusted for baseline clinical characteristics, including coronary artery disease, cerebrovascular disease, and renal malperfusion), elderly patients had a twofold higher risk of 30‐day mortality than non‐elderly patients (hazard ratio [HR] = 1.999, 95% confidence interval [CI]: 1.210–3.302; p = 0.007). After further adjustment for echocardiographic parameters, including LVESD, LVEDD, LVEF, aortic regurgitation, and pericardial effusion (Model 2), the association remained significant (HR = 2.077, 95% CI: 1.252–3.445; p = 0.005). In the fully adjusted model (Model 3), which additionally included intraoperative variables (e.g., operating time, CPB time, and concomitant CABG), age ≥ 60 years continued to be associated with a significantly elevated risk of early mortality (HR = 2.286, 95% CI: 1.361–3.840; p = 0.002). Collectively, these findings demonstrate that advanced age is independently associated with increased 30‐day mortality, with a consistent magnitude of effect across progressively adjusted models. Table S2 presents sensitivity analyses using alternative age thresholds and a summary of within‐elderly age heterogeneity. TABLE 5Univariable Cox regression analyses before and after propensity score matching (PSM).CharacteristicBefore PSMAfter PSMHR95% CI p HR95% CI p Age ≥ 60 (year)2.4601.667, 3.629< 0.0012.1731.320, 3.5790.002Gender (Male)0.9220.599, 1.4180.7121.1630.683, 1.9800.579BMI ≥ 26.21.0990.766, 1.5760.6091.2720.770, 2.1020.347Smoke0.7670.531, 1.1080.1580.9810.593, 1.6250.941Drunk0.7550.494, 1.1530.1941.1080.634, 1.9350.719Hypertension1.1400.734, 1.7730.5591.2750.679, 2.3930.450Diabetes1.2510.550, 2.8430.5930.8510.309, 2.3450.756Hyperlipidemia1.4500.675, 3.1130.3411.3400.537, 3.3420.531Marfan Syndrome2.7220.670, 11.0560.1612.6190.363, 18.8960.340Renal malperfusion3.2921.809, 5.992< 0.0012.7591.106, 6.8820.030History of CHD2.9311.533, 5.6060.0012.4171.041, 5.6090.040History of MI4.4421.411, 13.9800.0112.8410.394, 20.4990.300History of CVD4.4332.536, 7.751< 0.0015.5492.891, 10.650< 0.001History of heart surgery1.3210.487, 3.5840.5851.8140.569, 5.7860.314History of TEVAR0.5930.083, 4.2450.6031.1070.153, 7.9850.920History of aortic surgery0.8520.271, 2.6810.7841.3260.416, 4.2300.634History of PCI3.0840.980, 9.7060.0544.0900.999, 16.7380.050Aortic regurgitationNone————Mild1.2930.861, 1.9420.2161.4110.769, 2.5880.266Moderate1.4980.894, 2.5110.1251.6310.784, 3.3900.190Severe0.6360.253, 1.6010.3371.1900.347, 4.0840.782Mitral regurgitationNone————Mild0.7220.466, 1.1170.1430.8420.475, 1.4920.556Moderate0.6740.094, 4.8410.6950.8840.122, 6.4130.903Severe7.7851.916, 31.6250.0044.6830.645, 34.0020.127Tricuspid regurgitationNone————Mild0.4770.277, 0.8200.0070.4970.245, 1.0090.053Moderate0.8790.217, 3.5630.8560.5700.079, 4.1230.578Severe2.0550.287, 14.7340.4740.0000.000, Inf0.996Pericardial EffusionNone————Mild0.5920.326, 1.0770.0860.3940.158, 0.9850.046Moderate1.3640.432, 4.3030.5971.0540.257, 4.3200.942Severe0.0000.000, Inf0.9940.0000.000, Inf0.996LVESD ≥ 31 mm1.1070.761, 1.6090.5961.2770.769, 2.1220.345LVEDD ≥ 48 mm0.9560.666, 1.3710.8050.9580.582, 1.5780.867LVEF ≥ 62%1.3220.917, 1.9050.1341.9011.116, 3.2380.018Operating time ≥ 7 h3.8512.165, 6.850< 0.0014.3861.758, 10.9430.002CPB time ≥ 197 min2.1041.431, 3.094< 0.0012.1331.253, 3.6340.005ACC time ≥ 108 min1.4671.015, 2.1190.0411.1910.722, 1.9630.494HCA time ≥ 22 min0.7520.525, 1.0780.1210.8550.520, 1.4060.537Nasopharyngeal Temperature ≥ 24.5°C1.0020.699, 1.4370.9900.8410.510, 1.3840.495Rectal Temperature, Median ≥ 25.7°C0.6850.476, 0.9860.0420.6900.417, 1.1430.150Cannulation strategyAxillary or femoral cannulation————Dual arterial cannulation1.3620.939, 1.9770.1041.1930.700, 2.0320.516Cerebral perfusion approachUnilateral cerebral perfusion————Bilateral cerebral perfusion1.1470.677, 1.9420.6100.9030.445, 1.8290.776Concomitant CABG2.4071.439, 4.027< 0.0012.2631.228, 4.1710.009ICU LOS ≥ 51.3 h1.9861.353, 2.916< 0.0011.9301.140, 3.2650.014Reintubation3.4451.980, 5.994< 0.0013.0971.334, 7.1880.008Tracheostomy3.7342.159, 6.459< 0.0014.3812.160, 8.882< 0.001Positive Neuroimaging FindingsNegative————Positive6.0173.942, 9.185< 0.0016.2223.460, 11.188< 0.001Not tested0.6030.244, 1.4870.2720.6600.205, 2.1240.486Stroke8.8466.070, 12.891< 0.0018.4345.033, 14.134< 0.001Intracerebral hemorrhage10.9966.042, 20.013< 0.0015.5652.020, 15.334< 0.001Cerebral infarction7.1164.785, 10.584< 0.0017.6324.476, 13.012< 0.001Paraplegia1.6010.704, 3.6420.2621.1480.281, 4.6970.848PND6.9554.809, 10.058< 0.0016.5703.939, 10.959< 0.001Limb paralysis14.5824.442, 47.865< 0.0018.8741.228, 64.1170.030Limb ischemia6.7904.369, 10.552< 0.0016.9223.914, 12.241< 0.001Acute kidney injury6.2644.320, 9.082< 0.0013.6392.120, 6.245< 0.001Postoperative dialysis6.3634.420, 9.159< 0.0014.8752.943, 8.077< 0.001Cardiac tamponade5.9472.424, 14.589< 0.0015.6401.767, 18.0000.003Arrhythmia5.0033.424, 7.310< 0.0014.9452.992, 8.171< 0.001ECMO13.1887.910, 21.987< 0.0019.9404.896, 20.184< 0.001IABP1.1570.471, 2.8420.7510.6560.091, 4.7290.675Lung infection1.6911.019, 2.8070.0421.6240.825, 3.1940.160Pleural effusion0.7040.449, 1.1030.1260.6330.337, 1.1890.155Pneumothorax3.5491.904, 6.613< 0.0014.0021.604, 9.9850.003Respiratory failure4.9223.169, 7.643< 0.0015.0292.772, 9.126< 0.001Delayed sternal closure10.9625.681, 21.151< 0.0017.8523.142, 19.619< 0.001Postoperative bleeding2.9791.350, 6.5740.0073.1761.153, 8.7490.025Sternal dehiscence0.7490.098, 5.7310.7810.0000.000, Inf0.996Debridement0.6980.157, 3.1050.6370.0000.000, Inf0.996Incision infection0.5850.132, 2.5970.4810.0000.000, Inf0.995Sepsis5.9662.859, 12.451< 0.0012.070.287, 14.9320.471Reoperation5.6433.654, 8.716< 0.0015.3112.927, 9.639< 0.001Hospital‐LOS ≥ 12.8 day0.2310.146, 0.365< 0.0010.2430.132, 0.448< 0.001Abbreviations: ACC, aortic cross‐clamping; AR, aortic regurgitation; BMI, body mass index; CABG, coronary artery bypass grafting; CHD, coronary heart disease; CPB, cardiopulmonary bypass; CVD, cerebrovascular disease; ECMO, extracorporeal membrane oxygenation; HCA, hypothermic circulatory arrest; Hospital‐LOS, hospital length of stay; IABP, intra‐aortic balloon pump; ICU‐LOS, intensive care unit length of stay; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end‐systolic diameter; MI, myocardial infarction; MR, mitral regurgitation; PCI, percutaneous coronary intervention; PND, permanent neurological deficit; TR, tricuspid regurgitation. Univariable Cox regression analyses before and after propensity score matching (PSM). Abbreviations: ACC, aortic cross‐clamping; AR, aortic regurgitation; BMI, body mass index; CABG, coronary artery bypass grafting; CHD, coronary heart disease; CPB, cardiopulmonary bypass; CVD, cerebrovascular disease; ECMO, extracorporeal membrane oxygenation; HCA, hypothermic circulatory arrest; Hospital‐LOS, hospital length of stay; IABP, intra‐aortic balloon pump; ICU‐LOS, intensive care unit length of stay; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end‐systolic diameter; MI, myocardial infarction; MR, mitral regurgitation; PCI, percutaneous coronary intervention; PND, permanent neurological deficit; TR, tricuspid regurgitation. TABLE 6Association between age and survival (Cox regression).CharacteristicModel 1Model 2Model 3HR95% CI p HR95% CI p HR95% CI p Age ≥ 60 (before PSM)2.2371.509, 3.316< 0.0012.1471.424, 3.237< 0.0012.1251.407, 3.208< 0.001Age ≥ 60 (after PSM)1.9991.210, 3.3020.0072.0771.252, 3.4450.0052.2861.361, 3.8400.002 Note: Model 1: adjusted for history of CHD, history of CVD, and renal malperfusion. Model 2: adjusted for model 1, LVESD, LVEDD, LVEF, aortic regurgitation and pericardial effusion. Model 3: adjusted for model 1, model 2, operating time, concomitant CABG, and CPB time. Association between age and survival (Cox regression). Note: Model 1: adjusted for history of CHD, history of CVD, and renal malperfusion. Model 2: adjusted for model 1, LVESD, LVEDD, LVEF, aortic regurgitation and pericardial effusion. Model 3: adjusted for model 1, model 2, operating time, concomitant CABG, and CPB time. Difference in Characteristics for Survivors and Non‐Survivors Among Patients Aged ≥ 60 Years Among elderly patients (n = 258), non‐survivors were slightly older than survivors (65 vs. 63 years, p < 0.001). Sex distribution, BMI, smoking status, alcohol consumption, and major comorbidities were comparable between groups. A history of cerebrovascular disease was more prevalent in non‐survivors (13.5% vs. 4.5%, p = 0.048), whereas other baseline characteristics, including hypertension, diabetes, coronary artery disease, and echocardiographic parameters, showed no significant differences (Table S3). Regarding operative characteristics, non‐survivors had significantly longer operating time (8.0 vs. 7.5 h, p = 0.004) and prolonged CPB durations (211 vs. 193 min, p = 0.021). Other intraoperative variables, including ACC time, cerebral perfusion approach, and concomitant CABG, were similar between groups (Table S4). Postoperative outcomes differed markedly. Non‐survivors required longer ventilation support (100 vs. 44 h, p = 0.002) and were more likely to undergo tracheostomy (13.5% vs. 4.5%, p = 0.048). They also experienced substantially higher incidences of major complications, including stroke (35.1% vs. 4.5%, p < 0.001), cerebral infarction (32.4% vs. 4.5%, p < 0.001), permanent neurological deficit (35.1% vs. 6.8%, p < 0.001), limb ischemia (40.5% vs. 6.3%, p < 0.001), AKI (43.2% vs. 14.0%, p < 0.001), postoperative dialysis (48.6% vs. 14.9%, p < 0.001), arrhythmia (45.9% vs. 18.1%, p < 0.001), ECMO support (10.8% vs. 1.8%, p = 0.018), respiratory failure (27.0% vs. 8.1%, p = 0.003), and delayed sternal closure (8.1% vs. 0.5%, p = 0.011) (Table S5). Overall, among elderly patients with ATAAD undergoing TAR+FET, non‐survivors were characterized by slightly older age, longer operative times, and a significantly greater burden of severe postoperative complications, particularly involving the neurological, renal, and respiratory systems. Discussion In this large multicenter cohort spanning seven cardiovascular centers and managed under a standardized TAR+FET protocol, elderly patients (≥ 60 years) had significantly higher 30‐day mortality than non‐elderly patients after PSM (13.5% vs. 6.4%). In fully adjusted Cox models, age ≥ 60 years remained an independent predictor of 30‐day mortality (HR = 2.286, 95% CI: 1.361–3.840; p = 0.002). The divergence in survival rates became evident within the first postoperative week and persisted through 30 days. Among elderly patients, non‐survivors had longer operative and CPB times, required more prolonged ventilation, and had a higher incidence of tracheostomy. They also experienced significantly higher rates of major complications, including stroke, limb ischemia, dialysis‐dependent AKI, and respiratory failure. Collectively, these findings suggest that increased perioperative vulnerability, rather than procedural factors alone, contribute to the elevated early mortality observed in elderly patients. In our cohort, the median age at diagnosis was relatively young (49 years), consistent with contemporary Chinese registries reporting similar age distributions (Sino‐RAD, 49 ± 11.1 years; a national multicenter registry, 51.6 ± 11.7 years). In contrast, major Western datasets report substantially higher ages at presentation, typically in the early 60s (IRAD, 61.5 ± 14.6 years; NORCAAD, 61.5 ± 12.1 years; GERAADA, 61.4 ± 13.5 years). This geographic disparity should be considered when extrapolating findings and establishing age‐stratified benchmarks [11, 12, 13, 14, 15]. Beyond demographic differences, biological mechanisms of aging may also contribute to the development and prognosis of aortic dissection. Recent studies indicate that degenerative programs mediated by activator protein‐1 in vascular smooth muscle cells, the age‐related miR‐1204—MYLK axis, and broader pathways involving senescence and extracellular matrix remodeling increase vulnerability of the aortic wall, thereby linking aging to both disease susceptibility and prognosis [16, 17, 18, 19]. Building on this demographic and biological framework, we evaluated the impact of age on surgical outcomes. In experienced centers, short‐term outcomes following TAR+FET are generally acceptable. A representative large TAR+FET series using the Sun's procedure reported early mortality of 7.8%, with major neurologic or spinal complications in the single digits [3]. A meta‐analysis of TAR+FET for ATAAD reported a pooled early mortality of 9.2%, with similarly low rates of major neurologic events [4]. Our multicenter cohort, managed with a uniform operative strategy, is consistent with these benchmarks, with an overall 30‐day mortality of 7.1%. Importantly, our study extends prior work in three ways. First, by combining 1:2 PSM with fully adjusted Cox models, we more precisely isolate the association of age with early mortality. Second, time‐resolved analyses show that survival differences emerge within the first postoperative week and persist through 30 days. Third, within the elderly subgroup, we characterize early failure by comparing survivors and non‐survivors, identifying longer operative and CPB times, greater ventilatory support with higher tracheostomy rates, and significantly increased rates of stroke, limb ischemia, dialysis‐dependent AKI, and respiratory failure. These findings complement prior meta‐analytic evidence demonstrating an age‐related early risk in elderly TAR+FET cohorts [5, 6] and further suggesting that residual early risk is driven primarily by heightened perioperative vulnerability rather than procedural variability. Physiologic reserve refers to the capacity of multiple organ systems to tolerate and recover from major stress, whereas frailty represents a clinically meaningful state of vulnerability resulting from diminished reserve across systems [20]. Clinically, frailty can be screened using bedside tools such as the Clinical Frailty Scale [21]. Evidence from surgical cohorts indicates that preoperative frailty predicts postoperative complications and resource utilization, underscoring its relevance to perioperative risk stratification in older patients [22]. In cardiac surgery, frailty assessment provides prognostic information beyond conventional risk models and supports more informed perioperative counseling and shared decision‐making [23]. Among the elderly, non‐survivors had a higher prevalence of preexisting cerebrovascular disease, underwent longer surgical and CPB durations (8.0 vs. 7.5 h; 211 vs. 193 min), required prolonged ventilation with more frequent tracheostomy, and experienced higher rates of stroke, limb ischemia, dialysis‐requiring AKI, respiratory failure, and ECMO use. These findings align with previous research showing that cerebrovascular disease and prolonged CPB or cerebral perfusion increase the risk of postoperative stroke after type A or arch repair [24]. Furthermore, dialysis‐requiring AKI is a strong predictor of early mortality [25], postoperative tracheostomy identifies a high‐risk subgroup [26], and ECMO use after ATAAD is associated with significantly elevated in‐hospital mortality and complications [27]. Together with evidence from the frailty literature demonstrating greater perioperative vulnerability in older cardiac patients [28], our findings support multi‐organ vulnerability, rather than procedural complexity alone, as the principal driver of early mortality in the elderly. We hypothesize that elderly patients face increased early risk following TAR+FET due to three interrelated mechanisms. First, lower physiologic reserve associated with aging and frailty limits tolerance to surgical stress; simple bedside frailty measures provide prognostic information beyond conventional risk scores and help explain why some older patients deteriorate despite standardized care [29]. Second, exposure to CPB and hypothermia triggers a systemic stress response characterized by inflammation, endothelial injury, increased capillary permeability, and impaired microcirculatory flow, from which the brain, kidneys, and lungs of older adults recover less effectively [30]. Third, the impact of operative duration and procedural complexity is amplified in elderly patients. TAR+FET requires multiple anastomoses and cerebral‐protection maneuvers; contemporary series report CPB times of approximately 170–200 min and cross‐clamp times of 85–110 min, although “branch‐first” strategies may reduce these intervals [31]. Prolonged CPB, cerebral perfusion, or circulatory arrest is associated with increased stroke risk and organ injury after type A/arch repair [24], and longer CPB is linked to AKI and higher in‐hospital mortality, including in total‐arch cohorts where “extended CPB” is an independent risk factor [32]. Even modest delays may be clinically meaningful in frail older adults; both earlier and contemporary studies suggest that simplifying or accelerating arch strategies is advantageous in octogenarians [31, 33]. Clinically, the excess risk associated with advanced age likely reflects diminished physiologic reserve combined with greater baseline cerebrovascular, renal, and pulmonary vulnerability, which reduces tolerance to CPB, hypothermia, and prolonged ventilation and predisposes patients to early multi‐organ dysfunction. Accordingly, perioperative management in older patients should prioritize vigilant neurologic monitoring, proactive organ‐protective strategies, and early escalation of supportive care when clinical deterioration is suspected. Based on the vulnerability–stress framework, perioperative care should follow a comprehensive protocol to attenuate the initial insult and prevent secondary complications. For arrhythmia management, continuous telemetry and strict electrolyte control are essential. Continuation or initiation of β‐blocker therapy is recommended, and QT‐prolonging medications should be avoided. Clinically significant arrhythmias, including atrial fibrillation and ventricular tachyarrhythmias, should be managed according to established guideline‐based algorithms, with temporary pacing or defibrillation for hemodynamic instability [34]. For cerebral protection, moderate hypothermia combined with antegrade cerebral perfusion should be employed, along with strict blood pressure control, meticulous de‐airing, gradual rewarming, and scheduled neurological assessments during the first postoperative week, with prompt imaging for any emergent deficits [2]. For renal protection, a KDIGO‐based prevention should be implemented, including goal‐directed mean arterial pressure, maintenance of euvolemia, avoidance of nephrotoxins, close monitoring of urine output and serum creatinine, and glycemic control. Early initiation of renal replacement therapy should be considered in cases of persistent oliguria or rising creatinine accompanied by fluid overload [35]. For pulmonary protection, lung‐protective ventilation (6–8 mL/kg predicted body weight) with adequate positive end‐expiratory pressure and low driving pressure is recommended, along with avoidance of positive fluid balance, early but safe extubation, early mobilization, and effective analgesia [36]. In the management of elderly patients with ATAAD, clinical decision‐making should prioritize immediate safety while preserving favorable long‐term aortic remodeling. TAR+FET procedures inherently necessitate hypothermic circulatory arrest and prolonged CPB, both of which are associated with increased risks of neurologic events, AKI, pulmonary complications, and in‐hospital mortality. Prolonged circulatory arrest and CPB duration have been correlated with higher incidences of stroke and AKI in cohorts undergoing arch surgery [30, 37]. Consequently, in elderly or frail patients, or when distal aortic involvement is limited, strategies that minimize exposure to CPB and hypothermic circulatory arrest are preferable. Such strategies include initial proximal repair followed by staged TEVAR and type II hybrid arch repair, both of which have demonstrated acceptable safety and efficacy in elderly or complex cases [38, 39]. When arch intervention is required, the use of mild hypothermia combined with an endovascular balloon can reduce the duration of circulatory arrest. Experienced centers have also reported near‐normothermic/limited‐arrest FET techniques to further mitigate physiologic stress [40]. If the anticipated anatomic benefit is substantial and physiologic reserve is adequate, TAR+FET remains a reasonable single‐stage strategy; however, it should be performed in accordance with established guidelines, with strict attention to minimizing CPB and circulatory arrest times. Limitation This multicenter retrospective cohort has several inherent limitations. First, the observational design precludes causal inference, and residual confounding may persist. Second, participating centers were analyzed as a pooled cohort under a shared operative strategy, and the study was not designed to compare outcomes across individual centers. Third, exclusion of patients with missing essential data may have introduced selection bias and limited generalizability. Fourth, the number of events for uncommon complications was modest, reducing the precision of subgroup estimates. Conclusion In this multicenter cohort of patients with ATAAD treated with TAR+FET, age ≥ 60 years independently predicted higher 30‐day mortality and complication burden, with divergence emerging during the first postoperative week. Given broadly comparable operative metrics across age groups, the excess early risk likely reflects reduced physiologic reserve. Accordingly, careful procedure selection and rigorous organ‐protective perioperative strategies should be emphasized in elderly patients. Author Contributions Jiajun Liang and Yuan Xue conceived this article and conducted the data analysis. Yeting Lou contributed to data entry and management. Jiajun Liang, Yuan Xue, and Yeting Lou reviewed the literature and prepared the first draft of this manuscript. Yuanfei Zhao, Haiyang Li, Hongjia Zhang, Wenjian Jiang, Meili Wang, Tianxu Han, Zhou Liu, Xiaohan Zhong, and Hao Han critically reviewed and edited the manuscript, and approved the final version. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. Funding This work was supported by the National Natural Science Foundation of China (82241205, 82422007, 82370471, 82170487, 82470495, 82300538, 82400548, and 82500956), the Beijing Natural Science Foundation (JQ24038, 7232037, L232030, L242066, and L252151), Beijing Nova Program (20220484151), the Beijing Municipal Science & Technology Commission (Z221100007422015 and Z241100007724008), and the Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (ZLRL202317), Beijing Anzhen Hospital Science and Technology Innovation Fund (No. KCZD202203, KCQY202201, and AZ2023‐YQ‐04), Beijing Anzhen Hospital Special Program for High‐Level Research (2025AZB1003), and the Laboratory for Clinical Medicine, Capital Medical University, Beijing, China. Ethics Statement The study was approved by the institutional ethics committee (KS2024114). Consent The requirement for individual informed consent was waived due to the retrospective design. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Table S1: Standardized mean difference (SMD) balance before/after PSM. Table S2: Sensitivity analyses using alternative age thresholds for defining older patients. Table S3: Baseline Characteristics in survivors and non‐survivors in patients ≥ 60 years of age (n = 258). Table S4: Surgical details in survivors and non‐survivors in patients ≥ 60 years of age (n = 258). Table S5: Postoperative outcomes in survivors and non‐survivors in patients ≥ 60 years of age (n = 258).